28Dec/12

AbbVie Wants To Be Hunter, Not Hunted Post-Abbott Split – Forbes

AbbVie Wants To Be Hunter, Not Hunted Post-Abbott Split
Forbes
There are 10 drugs in the final so-called Phase III stage of drug development including a potentially promising next-generation hepatitis C drug; the intestinal gel Duopa for the treatment of advanced Parkinson’s disease; daclizumab for multiple
Which Abbott Is the One to Own Post-Split?Investorplace.com

all 5 news articles »

17Dec/12

Crunching the Abbott Spinoff Numbers (ABT, ABBV) : Small Cap Diligence – SmallCap Network

Crunching the Abbott Spinoff Numbers (ABT, ABBV) : Small Cap Diligence
SmallCap Network
Daclizumab, bardoxolone (chronic kidney disease), and elotuzumab (multiple myeloma) are all in Phase III trials, with about ten more solid developments in Phase II testing. As for Abbott Laboratories, the device and equipment manufacturer, it’s also a